Market Cap 579.78M
Revenue (ttm) 4.63M
Net Income (ttm) -201.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,344.28%
Debt to Equity Ratio 0.00
Volume 2,446,400
Avg Vol 2,337,918
Day's Range N/A - N/A
Shares Out 180.62M
Stochastic %K 20%
Beta 2.35
Analysts Strong Sell
Price Target $6.92

Company Profile

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate is PM359 for Chronic Granulomatous Disease, which is in Phase 1/2 clinical trial; PM577 for Wilson Disease, that is in preclinical studies; and PM647 to treat genetic disorder caused by mutations in the SERPINA1 gene, resulting in production of misfolded Z-AAT protein that accum...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 465 0013
Address:
60 First Street, Cambridge, United States
arg195
arg195 May. 8 at 7:27 PM
$PRME you got your sell signal when the pumpers came out and said "send"
0 · Reply
arg195
arg195 May. 8 at 6:32 PM
$PRME prme investors for the past 6 months watching space stocks
0 · Reply
StockMarketGuru
StockMarketGuru May. 8 at 5:29 PM
$PRME confidence coming back
0 · Reply
603stockgoat
603stockgoat May. 8 at 5:24 PM
$PRME it’s prime time baby!
0 · Reply
JasonCO
JasonCO May. 8 at 2:57 PM
$PRME send
0 · Reply
babyloncapital
babyloncapital May. 8 at 2:55 PM
$PRME Nice pa after yesterday. nicer if it sticks
0 · Reply
OwenG
OwenG May. 8 at 2:50 PM
$PRME 👀
0 · Reply
NewEarth
NewEarth May. 8 at 2:34 PM
$NTLA $BEAM $EDIT $REGN $PRME Jennifer and Intellia are going to hold the market of all these treatments
0 · Reply
603stockgoat
603stockgoat May. 8 at 2:30 PM
0 · Reply
FredGS
FredGS May. 8 at 2:01 PM
$PRME Just a scratch.
0 · Reply
Latest News on PRME
Prime Medicine reports Q1 EPS (28c), consensus (25c)

2026-05-07T19:46:03.000Z - 2 days ago

Prime Medicine reports Q1 EPS (28c), consensus (25c)


Prime Medicine management to meet with Oppenheimer

2026-05-07T02:02:00.000Z - 3 days ago

Prime Medicine management to meet with Oppenheimer


Prime Medicine appoints Makhni as Chief Financial Officer

2026-04-16T12:25:29.000Z - 23 days ago

Prime Medicine appoints Makhni as Chief Financial Officer


Prime Medicine initiated with an Outperform at Oppenheimer

2026-03-12T10:26:58.000Z - 2 months ago

Prime Medicine initiated with an Outperform at Oppenheimer


Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year

2026-03-03T13:07:13.000Z - 2 months ago

Prime Medicine reports FY25 EPS ($1.35) vs ($1.65) last year


Prime Medicine to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:00 AM EST - 2 months ago

Prime Medicine to Participate in Upcoming Investor Conferences


Prime Medicine initiated with an Outperform at LifeSci Capital

2025-12-23T13:50:25.000Z - 4 months ago

Prime Medicine initiated with an Outperform at LifeSci Capital


Prime Medicine announces NEJM publication of PM359 data

2025-12-07T18:30:05.000Z - 5 months ago

Prime Medicine announces NEJM publication of PM359 data


Prime Medicine transferred with Neutral rating at JPMorgan

2025-11-18T12:55:59.000Z - 6 months ago

Prime Medicine transferred with Neutral rating at JPMorgan


Prime Medicine Transcript: KOL Event

Nov 12, 2025, 8:00 AM EST - 6 months ago

Prime Medicine Transcript: KOL Event


Prime Medicine price target lowered to $4.25 from $5 at Citi

2025-11-11T11:36:03.000Z - 6 months ago

Prime Medicine price target lowered to $4.25 from $5 at Citi


Prime Medicine files automatic mixed securities shelf

2025-11-07T13:11:02.000Z - 6 months ago

Prime Medicine files automatic mixed securities shelf


Prime Medicine reports Q3 EPS (32c), consensus (25c)

2025-11-07T12:13:06.000Z - 6 months ago

Prime Medicine reports Q3 EPS (32c), consensus (25c)


Prime Medicine appoints Hawryluk as Chief Business Officer

2025-11-03T13:05:05.000Z - 6 months ago

Prime Medicine appoints Hawryluk as Chief Business Officer


Prime Medicine price target raised to $5 from $4 at Citi

2025-10-29T11:27:04.000Z - 6 months ago

Prime Medicine price target raised to $5 from $4 at Citi


Prime Medicine Announces Pricing of Public Offering

Jul 30, 2025, 9:33 PM EDT - 10 months ago

Prime Medicine Announces Pricing of Public Offering


Prime Medicine Announces Proposed Public Offering of Common Stock

Jul 30, 2025, 4:01 PM EDT - 10 months ago

Prime Medicine Announces Proposed Public Offering of Common Stock


Prime Medicine Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 1:15 PM EST - 1 year ago

Prime Medicine Transcript: Stifel 2024 Healthcare Conference


Prime Medicine Unveils Strategically Focused Pipeline

Sep 30, 2024, 7:01 AM EDT - 1 year ago

Prime Medicine Unveils Strategically Focused Pipeline


Alphabet Bought Up Two Slumping Stocks

May 12, 2024, 3:00 AM EDT - 2 years ago

Alphabet Bought Up Two Slumping Stocks

GOOG GOOGL GTLB


Prime Medicine Announces Pricing of Upsized Public Offering

Feb 14, 2024, 11:50 PM EST - 2 years ago

Prime Medicine Announces Pricing of Upsized Public Offering


Prime Medicine to Present at Upcoming Investor Conferences

Nov 8, 2023, 8:00 AM EST - 2 years ago

Prime Medicine to Present at Upcoming Investor Conferences


Prime Medicine to Present at Investor Conferences in June

May 31, 2023, 8:00 AM EDT - 3 years ago

Prime Medicine to Present at Investor Conferences in June


arg195
arg195 May. 8 at 7:27 PM
$PRME you got your sell signal when the pumpers came out and said "send"
0 · Reply
arg195
arg195 May. 8 at 6:32 PM
$PRME prme investors for the past 6 months watching space stocks
0 · Reply
StockMarketGuru
StockMarketGuru May. 8 at 5:29 PM
$PRME confidence coming back
0 · Reply
603stockgoat
603stockgoat May. 8 at 5:24 PM
$PRME it’s prime time baby!
0 · Reply
JasonCO
JasonCO May. 8 at 2:57 PM
$PRME send
0 · Reply
babyloncapital
babyloncapital May. 8 at 2:55 PM
$PRME Nice pa after yesterday. nicer if it sticks
0 · Reply
OwenG
OwenG May. 8 at 2:50 PM
$PRME 👀
0 · Reply
NewEarth
NewEarth May. 8 at 2:34 PM
$NTLA $BEAM $EDIT $REGN $PRME Jennifer and Intellia are going to hold the market of all these treatments
0 · Reply
603stockgoat
603stockgoat May. 8 at 2:30 PM
0 · Reply
FredGS
FredGS May. 8 at 2:01 PM
$PRME Just a scratch.
0 · Reply
MorganHoratio
MorganHoratio May. 8 at 1:44 PM
Google just released its updated 13F filing which shows all the stocks it owned as of the end of Q1: PayPay Corp (Tokyo-listed) - 3,125,000 $PL - 35,248,893 $PRME - 16,562,498 $RLAY - 1,564,173 $RVMD - 3,292,525 $SANA - 2,812,500 Google’s Q1 13F is here: Fintech, Real-time Earth, and Gene Editing! The 3.1M share stake in PayPay is a major power move into the East Asian payment ecosystem. Meanwhile, holding 35M shares of $PL (Planet Labs) signals that Google is weaponizing satellite data to give Gemini AI a "God’s eye view" of global logistics. Heavy bets on $PRME and $RVMD also prove that AI-driven oncology and gene editing are now core to Alphabet’s "Other Bets." Do you think the synergy between satellite data and fintech will lead to a breakthrough in 2026? Which of these strategic pivots are you most bullish on?
1 · Reply
R8NGER
R8NGER May. 8 at 1:17 PM
$PRME Still on watch. @sogenerous pick. With revenue down maybe a raise coming? It looks like they have enough cash through 2026 however.
1 · Reply
AcceleratorModel
AcceleratorModel May. 8 at 1:00 AM
$PRME I knew better than to jump back in here. Now I’m kinda pissed off.
0 · Reply
PorkchopSquats
PorkchopSquats May. 7 at 8:48 PM
$PRME Quite the lame report. Not worrisome yet, but if they miss filing the Wilson’s IND before July then the picture here changes quite a bit. Investors need clarity, not vague promises.
2 · Reply
Windytimes
Windytimes May. 7 at 7:51 PM
$PRME depressing
0 · Reply
FredGS
FredGS May. 7 at 7:47 PM
$PRME It's not like the burn rate should be a surprise.
2 · Reply
603stockgoat
603stockgoat May. 7 at 7:07 PM
$PRME sigh , I’ll just buy more here 🤔😎😂
0 · Reply
ATTAB0Y
ATTAB0Y May. 7 at 6:23 PM
1 · Reply
Biocontrol
Biocontrol May. 7 at 5:44 PM
$PRME I’m not thrilled about no-call. I have chosen to add and tell myself they are in a quiet period lol.
2 · Reply
Mcnulty_jimmy
Mcnulty_jimmy May. 7 at 5:18 PM
$PRME im listening to Deion
0 · Reply
arg195
arg195 May. 7 at 5:17 PM
$PRME notice how the "consolidation getting tighter" and "15 min chart" guys have totally disappeared 😂😂😂. You guys are just paying for a research project by your hard earned money. Oh, and they're gonna present the same thing over and over, nothing will be new
0 · Reply
buymoremakemore
buymoremakemore May. 7 at 5:00 PM
$PRME Giving these schmucks until Q3 ER to follow through with what they say is “on-track”.
1 · Reply